Drugs / pdmFlu vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06179446 | Dec 2023 → Sep 2025 | influenza | Pfizer | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pdmFlu vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06179446 ↗ |
| Known as | Pandemic Influenza modRNA (pdmFlu) Vaccine | “The study vaccine is called Pandemic Influenza modRNA (pdmFlu) Vaccine.” NCT06179446 ↗ |
| Modality | Messenger RNA (mRNA) | “MODIFIED RNA VACCINE CANDIDATES” NCT06179446 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT06179446 ↗ |